Kristen Fortney

Kristen Fortney serves as the CEO of BioAge Labs, a clinical stage biotechnology company focused on developing treatments for aging and age-related diseases, since September 2015. Additionally, Kristen holds advisory roles at Known Medicine, Retro Biosciences, and Humanity Inc. Furthermore, Kristen has been a Scientific Advisor at Insilico Medicine, Inc. since 2014, specializing in artificial intelligence applications for drug discovery and aging research. Prior to these positions, Kristen was a postdoctoral research fellow at Stanford University, where research centered on the genetics of exceptional human longevity, and completed a PhD in Bioinformatics from the University of Toronto.